Review Articles

Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?

Memorial Sloan Kettering Cancer Center, New York, NY, USA
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Vol. 104 No. 8 (2019): August, 2019 https://doi.org/10.3324/haematol.2018.208587